Aquatic Capital Management LLC Vertex Pharmaceuticals Inc Transaction History

Aquatic Capital Management LLC

  • $3.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$285.76 - $321.48 $7.03 Million - $7.91 Million
24,600 New
24,600 $7.1 Million
Q2 2022

Aug 15, 2022
BUY
$234.96 - $292.55 $234,960 - $292,550
1,000 New
1,000 $282,000
Q1 2022

May 16, 2022
SELL
$221.42 - $260.97 $22,142 - $26,097
-100 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$177.01 - $223.45 $17,701 - $22,345
100 New
100 $22,000

Others Institutions Holding VRTX

# of Institutions
1,724
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email